Clear Aligner case-volume growth measures physical treatment shipments while Clear Aligner revenue growth and total revenue growth show how volume, ASP, product mix, geography, and other factors convert into reported sales.
Listing facts
- SEC issuer name
- ALIGN TECHNOLOGY INC
- Ticker
- ALGN
- Exchange
- Nasdaq
- Instrument family
- Ordinary share
- SEC issuer CIK
- 0001097149
- Listing source refreshed
- 2026-09-13
- Reviewed security class
- Common Stock, $0.0001 par value
Market summary
Completed-session reference prices from IEX for Oct 1, 2026.
Open
$145.50
Completed session
High
$145.84
Completed session
Low
$143.46
Completed session
Close
$145.29
Completed session
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Price history
Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.
Screened reference metrics
These percentage measures use the same qualified observation window and normalize only explicitly registered positive split events. They are reference metrics, not total returns or benchmark-relative performance.
Window return
-7.42%
Aug 20, 2026–Sep 21, 2026
Range width
10.6%
Screened closing-price range
Latest range position
0.55%
Position within screened close range
Average close vs. start
-2.41%
Average screened close relative to starting close
About this market data
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.
Screened reference metrics use K9-qualified IEX reference history and only explicitly registered positive split events. They do not assert complete split history, consolidated U.S. market performance, or canonical adjusted prices.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.
Fundamental lens
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Profitability
Profitable
Is trailing-twelve-month net income positive?
Trailing-twelve-month net income is positive. As of 2026-06-30.
Net income (TTM): $413.6M
Cash generation
Positive free cash flow
Is trailing-twelve-month free cash flow positive?
Trailing-twelve-month operating cash flow less capital expenditures is positive. As of 2026-06-30.
Free cash flow (TTM): $633.6M
Liquidity
Current assets above liabilities
Do reported current assets cover reported current liabilities?
Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-06-30.
Current assets: $2.7B · Current liabilities: $1.9B
Recent operating direction
Unknown
What changed in the latest comparable reported results?
Comparable retained change history is not available through this reader.
How this lens works
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Statistics
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Revenue (TTM)
$4.1B
TTM through Jun 30, 2026
Operating income (TTM)
$547.6M
TTM through Jun 30, 2026
Net income (TTM)
$413.6M
TTM through Jun 30, 2026
Operating margin (TTM)
13.23%
TTM through Jun 30, 2026
Net margin (TTM)
9.99%
TTM through Jun 30, 2026
Gross profit (latest FY)
$2.7B
year ended Dec 31, 2025
Gross margin (latest FY)
67.19%
year ended Dec 31, 2025
Diluted EPS (latest FY)
$5.65
year ended Dec 31, 2025
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Current assets (latest FY)
$2.6B
balance sheet Dec 31, 2025
Current liabilities (latest FY)
$1.9B
balance sheet Dec 31, 2025
Working capital (latest FY)
$696.5M
balance sheet Dec 31, 2025
Current ratio (latest FY)
1.36×
balance sheet Dec 31, 2025
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Operating cash flow (TTM)
$755.7M
TTM through Jun 30, 2026
Capital expenditures (TTM)
$122.1M
TTM through Jun 30, 2026
Free cash flow (TTM)
$633.6M
TTM through Jun 30, 2026
Free cash flow margin (TTM)
15.31%
TTM through Jun 30, 2026
Share repurchases (latest FY)
$465.9M
year ended Dec 31, 2025
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Financials
Latest SEC-reported annual, quarterly, and trailing-twelve-month financials. Missing cells mean a supported fact is unknown for that period and is not treated as zero.
| Metric | Annual · 2025-12-31 | Latest quarter · 2026-06-30 | TTM · 2026-06-30 |
|---|---|---|---|
| Revenue | $4.03B Filed 2026-02-27 | $1.06B Filed 2026-08-05 | $4.14B Filed 2026-08-05 |
| Cost of revenue | $1.32B Filed 2026-02-27 | $298.76M Filed 2026-08-05 | $1.32B Filed 2026-08-05 |
| Gross profit | $2.71B Filed 2026-02-27 | $757.43M Filed 2026-08-05 | $2.82B Filed 2026-08-05 |
| Operating expenses | $2.17B Filed 2026-02-27 | $603.42M Filed 2026-08-05 | $2.27B Filed 2026-08-05 |
| Operating income | $545.76M Filed 2026-02-27 | $154.01M Filed 2026-08-05 | $547.59M Filed 2026-08-05 |
| Pretax income | $585.29M Filed 2026-02-27 | $148.69M Filed 2026-08-05 | $568.91M Filed 2026-08-05 |
| Income tax expense | $174.94M Filed 2026-02-27 | $40.4M Filed 2026-08-05 | $155.33M Filed 2026-08-05 |
| Net income | $410.35M Filed 2026-02-27 | $108.29M Filed 2026-08-05 | $413.58M Filed 2026-08-05 |
| Diluted EPS | $5.65 Filed 2026-02-27 | $1.51 Filed 2026-08-05 | Unavailable |
| Diluted shares | 72.59M Filed 2026-02-27 | 71.52M Filed 2026-08-05 | Unavailable |
| Operating cash flow | $593.22M Filed 2026-02-27 | $192.76M Filed 2026-08-05 | $755.7M Filed 2026-08-05 |
| Depreciation & amortization | $237.44M Filed 2026-02-27 | $40.13M Filed 2026-08-05 | $254.39M Filed 2026-08-05 |
| Capital expenditures | $102.45M Filed 2026-02-27 | $35.67M Filed 2026-08-05 | $122.13M Filed 2026-08-05 |
| Stock repurchases | $465.94M Filed 2026-02-27 | $66.93M Filed 2026-08-05 | $266.93M Filed 2026-08-05 |
| Cash | $1.09B Filed 2026-02-27 | $1.1B Filed 2026-08-05 | Unavailable |
| Current assets | $2.62B Filed 2026-02-27 | $2.66B Filed 2026-08-05 | Unavailable |
| Current liabilities | $1.92B Filed 2026-02-27 | $1.91B Filed 2026-08-05 | Unavailable |
| Total assets | $6.23B Filed 2026-02-27 | $6.42B Filed 2026-08-05 | Unavailable |
| Total liabilities | $2.18B Filed 2026-02-27 | $2.19B Filed 2026-08-05 | Unavailable |
| Stockholders’ equity | $4.05B Filed 2026-02-27 | $4.23B Filed 2026-08-05 | Unavailable |
Calculated from the latest TTM financials
TTM free cash flow margin
15.31%
Period ended 2026-06-30
TTM free cash flow
$633.57M
Period ended 2026-06-30
TTM net margin
9.99%
Period ended 2026-06-30
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.